FR2147970B1 - - Google Patents
Info
- Publication number
- FR2147970B1 FR2147970B1 FR7223875A FR7223875A FR2147970B1 FR 2147970 B1 FR2147970 B1 FR 2147970B1 FR 7223875 A FR7223875 A FR 7223875A FR 7223875 A FR7223875 A FR 7223875A FR 2147970 B1 FR2147970 B1 FR 2147970B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16053071A | 1971-07-07 | 1971-07-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2147970A1 FR2147970A1 (en) | 1973-03-11 |
FR2147970B1 true FR2147970B1 (en) | 1976-04-16 |
Family
ID=22577265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7223875A Expired FR2147970B1 (en) | 1971-07-07 | 1972-06-30 |
Country Status (11)
Country | Link |
---|---|
AU (1) | AU438646B2 (en) |
BE (1) | BE785574A (en) |
CA (1) | CA979457A (en) |
CH (1) | CH532594A (en) |
DE (1) | DE2230454A1 (en) |
ES (1) | ES404442A1 (en) |
FR (1) | FR2147970B1 (en) |
GB (1) | GB1317236A (en) |
NL (1) | NL7208908A (en) |
PH (1) | PH10149A (en) |
ZA (1) | ZA724521B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4427529A1 (en) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Process for the preparation of 1,2,4-triazine-3,5-diones |
US6787652B1 (en) | 1999-09-30 | 2004-09-07 | Pfizer, Inc. | 6-Azauracil derivatives as thyroid receptor ligands |
-
1971
- 1971-10-08 GB GB4707071A patent/GB1317236A/en not_active Expired
-
1972
- 1972-06-16 AU AU43533/72A patent/AU438646B2/en not_active Expired
- 1972-06-20 PH PH13640A patent/PH10149A/en unknown
- 1972-06-22 DE DE2230454A patent/DE2230454A1/en active Pending
- 1972-06-28 NL NL7208908A patent/NL7208908A/xx unknown
- 1972-06-29 BE BE785574A patent/BE785574A/en unknown
- 1972-06-29 CH CH977472A patent/CH532594A/en not_active IP Right Cessation
- 1972-06-30 FR FR7223875A patent/FR2147970B1/fr not_active Expired
- 1972-06-30 CA CA146,141A patent/CA979457A/en not_active Expired
- 1972-06-30 ZA ZA724521A patent/ZA724521B/en unknown
- 1972-07-01 ES ES404442A patent/ES404442A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ZA724521B (en) | 1973-03-28 |
FR2147970A1 (en) | 1973-03-11 |
AU438646B2 (en) | 1973-08-16 |
DE2230454A1 (en) | 1973-01-25 |
AU4353372A (en) | 1973-08-16 |
GB1317236A (en) | 1973-05-16 |
NL7208908A (en) | 1973-01-09 |
PH10149A (en) | 1976-09-06 |
BE785574A (en) | 1972-12-29 |
ES404442A1 (en) | 1976-03-01 |
CH532594A (en) | 1973-01-15 |
CA979457A (en) | 1975-12-09 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |